Billionaire Peter Thiel, along with the investment firm Founders Fund, has completely sold their stakes in the treasury company ETHZilla, as revealed by the filing of Form 13G with the U.S. Securities and Exchange Commission (SEC).
This is reported by Business • Media
Investment History and Impact on ETHZilla’s Shares
ETHZilla, which previously operated under the name 180 Life Sciences, rebranded in July 2025 and focused on a strategy of accumulating Ethereum. In August 2025, Peter Thiel and Founders Fund acquired 7.5% of ETHZilla’s shares through their funds, which triggered a sharp increase in the company’s stock value—over 90% in a short time.
“Their investments in the company led to a 90% surge in its shares in August 2025.”
However, according to the latest reports, both investors have completely reduced their stakes to zero. Following this, the pre-market value of ETHZilla’s shares fell by approximately 7%.
Company Financials and Strategy
ETHZilla is among the DAT-type companies that recently adjusted their portfolios due to increased market volatility. In October 2025, the company sold Ethereum worth about $40 million to fund a stock buyback program.
As of the end of January 2026, ETHZilla controlled 65,850 ETH and is among the top ten public holders of this digital asset. The average purchase price of the asset by the firm is not disclosed.
ETHZilla stock price on Nasdaq. Source: TradingView.